Advanced Oncotherapy PLC Company Profile (LON:AVO)

Consensus Ratings for Advanced Oncotherapy PLC (LON:AVO)(?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.

Advanced Oncotherapy PLC is a United Kingdom-based specialist developer and provider of the particle therapy systems with protons that makes radiation less toxic for patients. The principal activity of the Company is to provide medical technology for cancer treatment and managing a health-related property. The Company operates in four segments: Development of proton therapy UK, Development of proton therapy Switzerland, Healthcare related properties UK and SD-IORT Services UK. The Company's subsidiaries include CareCapital Ltd, The Women's Cancer Centre Ltd, CareCapital (Southampton) Ltd, CareCapital Gesundheitsimmobilien Vervaltungs GmbH, CareCapital Gesundheitsimmobilien GmbH and Oncotherapy Resources Ltd.